Evidence map›Paper›PMID 30753383›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

The SHIELD Orange County Project: Multidrug-resistant Organism Prevalence in 21 Nursing Homes and Long-term Acute Care Facilities in Southern California.

James A McKinnell, Raveena D Singh, Loren G Miller, Ken Kleinman, Gabrielle Gussin, Jiayi He, Raheeb Saavedra, Tabitha D Dutciuc, Marlene Estevez, Justin Chang and 29 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Colonization with multidrug-resistant organisms (MDROs) includingInfection control and hospital epidemiology · 2026
    Article
  5. A Public Health Approach to Antimicrobial Stewardship in Long-term Care Facilities: A Multifaceted Program in Massachusetts.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  6. Surveillance for Candida auris - United States, 2022-2024.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Prevalence and risk factors for carriage of carbapenem-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Rapid Environmental Contamination With Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized Patients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

James A McKinnellInfectious Disease Clinical Outcomes Research, LA Biomed at Harbor-University of California Los Angeles Medical Center, Torrance.
Raveena D SinghDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Loren G MillerInfectious Disease Clinical Outcomes Research, LA Biomed at Harbor-University of California Los Angeles Medical Center, Torrance.
Ken KleinmanUniversity of Massachusetts Amherst School of Public Health and Health Sciences, Orange.
Gabrielle GussinDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Jiayi HeDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Raheeb SaavedraDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Tabitha D DutciucDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Marlene EstevezDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Justin ChangDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Lauren HeimDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Stacey YamaguchiDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Harold CustodioDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Shruti K GohilDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Steven ParkUniversity of California Irvine Health, Orange.
Steven TamDivision of Geriatrics, Department of Medicine, University of California Irvine, Orange.
Philip A RobinsonHoag Hospital, Newport, California.
Thomas TjoaDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Jenny NguyenDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.
Kaye D EvansUniversity of California Irvine Health, Orange.
Cassiana E BittencourtUniversity of California Irvine Health, Orange.
Bruce Y LeeJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Leslie E MuellerJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Sarah M BartschJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
John A JerniganDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Rachel B SlaytonDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Nimalie D StoneDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Matthew ZahnEpidemiology and Assessment, Orange County Health Care Agency, Santa Ana, California.
Vincent MorDepartment of Health Services, Policy and Practice, Brown University School of Public Health, Rhode Island.
Kevin McConeghyDepartment of Health Services, Policy and Practice, Brown University School of Public Health, Rhode Island.
Rosa R BaierDepartment of Health Services, Policy and Practice, Brown University School of Public Health, Rhode Island.
Lynn JanssenHealthcare-associated Infections Program, Center for Healthcare Quality, California Department of Public Health, Richmond, California.
Kathleen O'DonnellEpidemiology and Assessment, Orange County Health Care Agency, Santa Ana, California.
Robert A WeinsteinCook County Health and Hospitals System, Chicago, Illinois.
Mary K HaydenDepartment of Medicine, Rush University Medical Center, Chicago, Illinois.
Micaela H CoadyDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Megha BhattaraiDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Ellena M PetersonUniversity of California Irvine Health, Orange.
Susan S HuangDivision of Infectious Diseases, University of California Irvine School of Medicine, Orange.

Funding

Translational Training Grant in Experimental TherapeuticsK12CA133250 · NCI · OHIO STATE UNIVERSITY · PI WILLIAM E. CARSON, Rosa Lapalombella · 2008 to 2026
$15.0M
Regional Healthcare Ecosystem Analyst for Healthcare Associated InfectionsR01HS023317 · AHRQ · JOHNS HOPKINS UNIVERSITY · PI LEE, BRUCE Y · 2014 to 2014
$2.4M
AHRQ HHS R01 HS023317
6 · The paper itself

Abstract

backgroundMultidrug-resistant organisms (MDROs) spread between hospitals, nursing homes (NHs), and long-term acute care facilities (LTACs) via patient transfers. The Shared Healthcare Intervention to Eliminate Life-threatening Dissemination of MDROs in Orange County is a regional public health collaborative involving decolonization at 38 healthcare facilities selected based on their high degree of patient sharing. We report baseline MDRO prevalence in 21 NHs/LTACs.

methodsA random sample of 50 adults for 21 NHs/LTACs (18 NHs, 3 LTACs) were screened for methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus spp. (VRE), extended-spectrum β-lactamase-producing organisms (ESBL), and carbapenem-resistant Enterobacteriaceae (CRE) using nares, skin (axilla/groin), and peri-rectal swabs. Facility and resident characteristics associated with MDRO carriage were assessed using multivariable models clustering by person and facility.

resultsPrevalence of MDROs was 65% in NHs and 80% in LTACs. The most common MDROs in NHs were MRSA (42%) and ESBL (34%); in LTACs they were VRE (55%) and ESBL (38%). CRE prevalence was higher in facilities that manage ventilated LTAC patients and NH residents (8% vs <1%, P < .001). MDRO status was known for 18% of NH residents and 49% of LTAC patients. MDRO-colonized adults commonly harbored additional MDROs (54% MDRO+ NH residents and 62% MDRO+ LTACs patients). History of MRSA (odds ratio [OR] = 1.7; confidence interval [CI]: 1.2, 2.4; P = .004), VRE (OR = 2.1; CI: 1.2, 3.8; P = .01), ESBL (OR = 1.6; CI: 1.1, 2.3; P = .03), and diabetes (OR = 1.3; CI: 1.0, 1.7; P = .03) were associated with any MDRO carriage.

conclusionsThe majority of NH residents and LTAC patients harbor MDROs. MDRO status is frequently unknown to the facility. The high MDRO prevalence highlights the need for prevention efforts in NHs/LTACs as part of regional efforts to control MDRO spread.

Indexed as

CaliforniaCarbapenem-Resistant EnterobacteriaceaeChlorhexidineDrug Resistance, Multiple, BacterialEnterobacteriaceae InfectionsHumansLong-Term CareMethicillin-Resistant Staphylococcus aureusNursing HomesPrevalencePublic HealthStaphylococcal InfectionsVancomycin-Resistant EnterococciChlorhexidinechlorhexidineCREdecolonizationlong term careMRSApublic health

Identifiers

PMID30753383
PMCPMC7320073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.